Health
Cigarette maker BAT announces US vaccine trial launch – Medical Xpress
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed…
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
The group said the US Food and Drug Administration has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
Study results are expected in mid-2021, when the group hopes to progress to a phase two trial on the project, which is being run on a…
-
General8 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News15 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General19 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General18 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba